# Kirin Holdings

> Kirin Holdings is a VC fund backing Food and Beverage and Health Care. See 20 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tokyo, Japan
- Total investments: 20
- Last investment: Nov 2024
- Lead investor: 40%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/kirin-holdings/
- Website: http://www.kirinholdings.co.jp/

Kirin Holdings is a VC fund in Tokyo focused on Food and Beverage and Health Care. Kirin Holdings manufactures and sells alcoholic and non-alcoholic beverages, and pharmaceuticals, and bio-chemicals in Japan and internationally. It operates through four segments: Japan Integrated Beverages Business, Oceania Integrated Beverages Business, Other Overseas Integrated Beverages Business, and Pharmaceuticals and Bio-Chemicals Business.Kirin Holdings' products include beer, happo-shu, wine, whiskey, spirits, soft drinks, dairy products, fruit juices, and other products. It also produces and sells pharmaceutical products, biochemical products, and other products. Moreover, Kirin Holdings engages in the livestock feed and theme park businesses; and management and operation of a chain of Kirin City beer pubs; manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use bulk pharmaceuticals, as well as margarine, jams, and honey. Further, it is involved in the manufacture and sale of Coca-Cola products and other soft drinks, as well as sake; and manufacture and supply of Four Roses bourbon. Kirin Holdings has a strategic collaboration with Mitsui and Onegevity Health for launching a testing system in Japan, as well as to develop nutritional products. Kirin Brewery began operation in 1907 became Kirin Holdings in July 2007, with its headquarters in Tokyo in Japan.

## Contacts

5 contacts available for Kirin Holdings. Shizune tracks 2 team members at Kirin Holdings. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/kirin-holdings?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series B | $3.4M–$17M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Food and Beverage | 5 | 25% |
| Health Care | 4 | 20% |
| Biotechnology | 3 | 15% |
| SaaS | 1 | 5% |
| Sports | 1 | 5% |

38 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 4 | 20% |
| Seed | 3 | 15% |
| Corporate Round | 3 | 15% |
| Series A | 2 | 10% |
| Series D | 2 | 10% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Japan | 10 | 50% |
| United States | 2 | 10% |
| India | 1 | 5% |
| Sweden | 1 | 5% |
| Finland | 1 | 5% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Thomas Blake Glover | Founder | 0 | https://shizune.co/investors/profile/thomas-blake-glover |
| William Copeland | Founder | 0 | https://shizune.co/investors/profile/william-copeland-231f |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Tacoms | CAMEL is a service that allows you to easily manage orders from multiple food delivery / takeout services on a single tablet. | $6.1M | Series B | Nov 13, 2024 |  |
| ThinkCyte | ThinkCyte provides single-cell analysis for research, diagnostics, and therapeutics with an integrated multidisciplinary approach. | $14.8M | Series C | Aug 29, 2024 |  |
| Rhelixa | Rhelixa is a leader in epigenome analysis.We analyze genomes, epigenomes, and transcriptomes using our proprietary technologies to dramatically improve the efficiency and accuracy of R & D. | $3.4M | Series B | Aug 20, 2024 |  |
| Bira 91 | Bira 91 is a craft beer brand that produces and offers 5 flavorful varieties in its portfolio.The company's five beers, Bira 91 White, a low bitterness wheat beer, Bira 91 Blonde, an extra hoppy craft lager, Bira 91 Light, a low-calorie lunchtime lager, Bira 91 Strong, a high intensity, high alcohol wheat beer, and Bira 91 “The IPA”, thefirst IPA brewed and bottled in locally. It operates four breweries and is backed by Sequoia Capital India, Sofina, Sixth Sense Ventures, Neoplux, and Kirin Holding.Ankur Jain established the New Delhi, Delhi, India-based company in 2015. | $50M | Series D | Feb 19, 2024 |  |
| Euphoria | Euphoria is a Sports marketing company.Euphoria is a provision of IT solutions in the sports field (conditioning management, database development, consulting). |  | Series D | Nov 29, 2023 |  |
| Bira 91 | Bira 91 is a craft beer brand that produces and offers 5 flavorful varieties in its portfolio.The company's five beers, Bira 91 White, a low bitterness wheat beer, Bira 91 Blonde, an extra hoppy craft lager, Bira 91 Light, a low-calorie lunchtime lager, Bira 91 Strong, a high intensity, high alcohol wheat beer, and Bira 91 “The IPA”, thefirst IPA brewed and bottled in locally. It operates four breweries and is backed by Sequoia Capital India, Sofina, Sixth Sense Ventures, Neoplux, and Kirin Holding.Ankur Jain established the New Delhi, Delhi, India-based company in 2015. | $70M | Series D | Nov 21, 2022 |  |
| Neutral | Neutral is a carbon-neutral food company that builds a sustainable carbon-neutral food ecosystem starting with milk and a half and half.The company was founded in 2018 and is based in Portland, OR. | $12M | Series A | Aug 31, 2022 |  |
| Flow Neuroscience | Flow Neuroscience is a healthcare company that develops depression treatment devices that combines an easy-to-use brain stimulation headset with a personalized mobile app to target both the physical and behavioral elements of Major Depressive Disorder (MDD). The company's wearable stimulates a patient's left frontal lobe, the area of thebrain that has often lowered activity in people suffering from depression.Flow Neuroscience combines their wearable with a mobile app that nudges users to behaviors that will help lessen the effects of their depression, including exercise and regular sleeping patterns.The company's hope is to make available for the public a treatment that's currently only used in clinics specialized in brain stimulation. It also wants to make the treatment affordable enough to seriously challenge a dominant pharmaceuticals industry. | $10M | Series A | Aug 10, 2021 |  |
| Rehab | Rehab develops a rehabilitation support SaaS "Rehaplan" for adult day care centers. | $6.4M | Series B | May 24, 2021 |  |
| DAIZ | DAIZ produces and sells plant-based meat, 'Miracle Meat' which uses germinated soybeans by the proprietary 'Ochiai Germination Method.' Also, DAIZ engages in research and development of raw materials, and drug discovery from germinated soybeans. | $16.7M | Series B | Mar 31, 2021 |  |

10 of 20 investments shown.

## Co-investors
- [Global Brain Corporation](https://shizune.co/investors/profile/global-brain-corporation) — VC Fund, 9 deals together
- [01booster](https://shizune.co/investors/profile/01booster) — VC Fund, 3 deals together
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund, 3 deals together
- [Daiwa Corporate Investment](https://shizune.co/investors/profile/daiwa-corporate-investment) — VC Fund, 2 deals together
- [NTT DOCOMO Ventures](https://shizune.co/investors/profile/ntt-docomo-ventures) — VC Fund, 2 deals together
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Imaginary Ventures](https://shizune.co/investors/profile/imaginary-ventures) — VC Fund
- [Distill Ventures](https://shizune.co/investors/profile/distill-ventures) — VC Fund
- [InvestBev](https://shizune.co/investors/profile/investbev) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Chalmers Ventures AB](https://shizune.co/investors/profile/chalmers-ventures) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

## Featured in investor lists
- [Wine And Spirits VC Funds](https://shizune.co/investors/wine-and-spirits-vc-funds)
- [Wine And Spirits Investors in India](https://shizune.co/investors/wine-and-spirits-investors-india)
- [Wine And Spirits VC Funds in India](https://shizune.co/investors/wine-and-spirits-vc-funds-india)
- [Wine And Spirits Investors](https://shizune.co/investors/wine-and-spirits-investors)
- [Medical Device Investors in Sweden](https://shizune.co/investors/medical-device-investors-sweden)
- [Medical Device VC Funds in Sweden](https://shizune.co/investors/medical-device-vc-funds-sweden)

## FAQ

### What does Kirin Holdings invest in?

Kirin Holdings invests primarily in Food and Beverage, Health Care and Biotechnology startups, most often at Series B and Seed stage. Most of the 20 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Kirin Holdings's check size?

Kirin Holdings typically joins rounds of $3.4M–$17M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Kirin Holdings participates in.

### How do I contact Kirin Holdings?

Public channels for Kirin Holdings include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Kirin Holdings?

The team at Kirin Holdings includes Thomas Blake Glover (Founder) and William Copeland (Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co